Insights into Pacira BioSciences's Upcoming Earnings

Pacira BioSciences (NASDAQ:PCRX) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-06. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Pacira BioSciences will report an earnings per share (EPS) of $0.70.

Anticipation surrounds Pacira BioSciences's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Overview of Past Earnings

Last quarter the company beat EPS by $0.19, which was followed by a 5.68% increase in the share price the next day.

Here's a look at Pacira BioSciences's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

0.70

0.62

0.88

0.79

EPS Actual

0.89

0.62

0.89

0.72

Price Change %

6.0%

12.0%

-3.0%

6.0%

Tracking Pacira BioSciences's Stock Performance

Shares of Pacira BioSciences were trading at $16.45 as of November 04. Over the last 52-week period, shares are down 45.22%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

Analyst Observations about Pacira BioSciences

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Pacira BioSciences.

Analysts have given Pacira BioSciences a total of 7 ratings, with the consensus rating ...